Enzymes |
CHEBI:133004 – bisbenzylisoquinoline alkaloid |
Indoles and derivatives |
Antineoplastic agents |
Kinase |
Phosphorylation (GO:0016310) |
Neoplasms (C04 (D009369)) |
Disease of cellular proliferation (DOID:14566) |
CHEBI:50047 – organic amino compound |
Macrolides and Analogues |
Antivirals for systemic use |
Enzyme |
Cellular protein modification process (GO:0006464) |
Cardiovascular diseases (C14 (D002318)) |
Organ system cancer (DOID:0050686) |
CHEBI:24698 – hydroxyflavone |
|
Drugs for obstructive airway diseases |
Camk (CAMK protein kinase group) |
Receptor signaling protein activity (GO:0005057) |
Urologic diseases (C12.777 (D014570)) |
Kidney disease (DOID:557) |
CHEBI:24921 – isoquinoline alkaloid |
|
|
Ste (STE protein kinase group) |
Transferase activity (GO:0016740) |
Kidney diseases (C12.777.419 (D007674)) |
Urinary system disease (DOID:18) |
|
|
|
|
Adenyl nucleotide binding (GO:0030554) |
|
|
|
GPCRs |
CHEBI:33853 – phenols |
Morphinans |
Psycholeptics |
Small molecule receptor (family A GPCR) |
Cell–cell signaling (GO:0007267) |
Nervous system diseases (C10 (D009422)) |
Disease of mental health (DOID:150) |
CHEBI:72720 – flavonoid oligomer |
Benzofurans |
Drugs for obstructive airway diseases |
Transporter |
Circulatory system process (GO:0003013) |
Cardiovascular diseases (C14 (D002318)) |
Central nervous system disease (DOID:331) |
CHEBI:33822 – organic hydroxy compound |
Stilbenes |
Bile and liver therapy |
7TM1 (family A G protein-coupled receptor) |
Plasma membrane region (GO:0098590) |
Neurologic manifestations (C23.888.592 (D009461)) |
Genetic disease (DOID:630) |
CHEBI:33635 – polycyclic compound |
|
Antihistamines for systemic use |
Electrochemical transporter |
Transmembrane transporter activity (GO:0022857) |
Pituitary diseases (C19.700 (D010900)) |
Disease of metabolism (DOID:0014667) |
|
Nuclear receptors |
CHEBI:51958 – organic polycyclic compound |
Steroids and steroid derivatives |
Antineoplastic agents |
Transcription factor |
Intracellular receptor signaling pathway (GO:0030522) |
Neoplasms (C04 (D009369)) |
Disease of cellular proliferation (DOID:14566) |
CHEBI:33635 – polycyclic compound |
Morphinans |
Corticosteroids for systemic use |
Nuclear receptor |
Nucleic acid binding transcription factor activity (GO:0001071) |
Immune system diseases (C20 (D007154)) |
Cancer (DOID:162) |
CHEBI:36615 – triterpenoid |
Prenol lipids |
Anti-acne preparations |
Cytochrome P450 |
Programmed cell death (GO:0012501) |
Hemic and lymphatic diseases (C15 (D006425)) |
Immune system disease (DOID:2914) |
CHEBI:25872 – pentacyclic triterpenoid |
Stilbenes |
Analgesics |
AUXTRANS (Auxiliary transport protein) |
Positive regulation of apoptotic process (GO:0043065) |
Skin and connective tissue diseases (C17 (D017437)) |
Hypersensitivity reaction disease (DOID:0060056) |
|
|
Sex hormones and modulators of the genital system |
|
|
|
|
|
Ion channels |
CHEBI:47916 – flavonoid |
Morphinans |
Antihistamines for systemic use |
Ste (STE protein kinase group) |
Phosphorylation (GO:0016310) |
Neoplasms (C04 (D009369)) |
Disease of cellular proliferation (DOID:14566) |
CHEBI:26004 – phenylpropanoid |
Benzopyrans |
Beta blocking agents |
Camk (CAMK protein kinase group) |
Receptor signaling protein activity (GO:0005057) |
Skin and connective tissue diseases (C17 (D017437)) |
Organ system cancer (DOID:0050686) |
CHEBI:26195 – polyphenol |
Benzene and substituted derivatives |
Drugs for obstructive airway diseases |
Ion channel |
Transmembrane transport (GO:0055085) |
Neurologic manifestations (C10.597 (D009461)) |
Gastrointestinal system disease (DOID:77) |
CHEBI:38443 – 1-benzopyran |
|
Analgesics |
Transporter |
Cell death (GO:0008219) |
Respiratory tract diseases (C08 (D012140)) |
Cardiovascular system disease (DOID:1287) |
|
Others |
CHEBI:33822 – organic hydroxy compound |
Macrolactams |
Antimycobacterials |
Cytosolic other |
Proteasome complex (GO:0000502) |
Cardiovascular diseases (C14 (D002318)) |
Disease of anatomical entity (DOID:7) |
CHEBI:26004 – phenylpropanoid |
Diazines |
Agents acting on the renin–angiotensin system |
ATP binding cassette |
Ribosome (GO:0005840) |
Nervous system diseases (C10 (D009422)) |
Cardiovascular system disease (DOID:1287) |
CHEBI:47916 – flavonoid |
Carboxylic acids and derivatives |
Lipid modifying agents |
Cytochrome P450 |
Antigen processing and presentation (GO:0019882) |
Vascular diseases (C14.907 (D014652)) |
Disease of cellular proliferation (DOID:14566) |
CHEBI:25036 – lignan |
|
Antivirals for systemic use |
Transporter |
Enzyme inhibitor activity (GO:0004857) |
Pathological conditions, signs and symptoms (C23 (D013568)) |
Primary bacterial infectious disease (DOID:0050338) |
|
|
|
Phosphodiesterase |
|
|
|
|
Renin (case study) |
CHEBI:35352 – organonitrogen compound |
Morphinans |
Antineoplastic agents |
Kinase |
Phosphorylation (GO:0016310) |
Neoplasms (C04 (D009369)) |
Disease of cellular proliferation (DOID:14566) |
CHEBI:26188 – polyketide |
Macrolides and analogues |
Pituitary and hypothalamic hormones and analogues |
Tk (TK protein kinase group) |
Receptor signaling protein activity (GO:0005057) |
Cardiovascular diseases (C14 (D002318)) |
Organ system cancer (DOID:0050686) |
CHEBI:46845 – N-alkylpiperazine |
Lactams |
Endocrine therapy |
Cmgc (CMGC protein kinase group) |
Adenyl nucleotide binding (GO:0030554) |
Vascular diseases (C14.907 (D014652)) |
Vascular disease (DOID:178) |
CHEBI:37578 – halide |
Benzodiazepines |
|
Agc (AGC protein kinase group) |
Guanyl-nucleotide exchange factor activity (GO:0005085) |
Digestive system diseases (C06 (D004066)) |
Urinary system disease (DOID:18) |